Rep. Thomas Kean Still Trading Stocks Amid Months-Long Absence
Rep. Thomas Kean has acknowledged trading stocks during his absence from Congress, which has lasted for several months. He has missed over 100 votes since his last participation on March 5, citing a personal health matter without providing many details. Kean has indicated that he expects to return to voting and campaigning soon, as he continues to engage with fellow Republicans by phone.
- ▪Kean signed off on five stock trades between April 14 and May 17 while missing more than 100 votes.
- ▪He has not been photographed in public for weeks and has canceled several planned appearances.
- ▪Kean stated that his doctors are confident he will make a full recovery and return to the campaign trail within weeks.
2 outlets in our directory ran this story, first to last over 5 hours. All of the coverage we found sits in one bucket: right. That one-sidedness is itself worth noticing.
- ▪ Thomas Kean Jr. signs off on stock trades despite monthslong House absence — Washington Examiner
Forbes — Business files mainly under business. We currently carry 837 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | Forbes — Business |
| Canonical URL | https://www.forbes.com/sites/saradorn/2026/05/26/rep-thomas-kean-still-trading-stocks-amid-months-long-absence/ |
| Publication time | Tue, 26 May 2026 12:37:01 -0400 |
| Retrieval time | 2026-05-26T16:47:50.047Z |
| Last seen | 2026-05-26T16:47:50.047Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | qBZ9V-DVnrgW · 2 stories |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
BreakingBusinessRep. Thomas Kean Still Trading Stocks Amid Months-Long AbsenceBySara Dorn,Forbes Staff. Sara Dorn is a Forbes news reporter who covers politics.Follow AuthorMay 26, 2026, 12:37pm EDTToplineRep. Thomas Kean, R-N.J., signed a congressional disclosure form Friday acknowledging a series of stock trades during his months-long absence from Congress—as the mystery surrounding his disappearance deepens. Rep. Tom Kean, Jr., R-N.J., participates in a House Transportation Committee hearing on Thursday, June 27, 2024.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Forbes — Business.
Discussion
0 commentsMore from Forbes — Business
